Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Recursion Pharmaceuticals Inc (RXRX) vs SpaceX (SPCX) Price & Performance

Recursion Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Recursion Pharmaceuticals Inc vs SpaceX — how do they compare? Recursion Pharmaceuticals Inc trades at $3.37 (market cap $1.81B), while SpaceX trades at $134.89 (market cap $1.76T). The key difference: SpaceX is far larger — about 972.4× Recursion Pharmaceuticals Inc's market cap, and SpaceX is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

RXRXSPCX
Market Cap
$1.81B$1.76T
Sector
HealthTechnology
52-Week High
$6.79$202.09
52-Week Low
$2.84$108.27
Enterprise Value
$1.33B$1.70T

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX

About SpaceX

SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.

Read more on SPCX